Literature DB >> 21336201

Effect of vascular endothelial growth factor 121 adenovirus transduction in rabbit model of femur head necrosis.

Yu-gang Liu1, Yue Zhou, Xu Hu, Jian-jun Fu, Yong Pan, Tong-wei Chu.   

Abstract

BACKGROUND: Our objective was to observe the role of vascular endothelial growth factor (VEGF) 121 gene transfer in promoting vascular reconstruction and bone repair in femur head necrosis of rabbits.
METHODS: The femoral head necrosis model was induced by injection with ethanol. The necrotic femoral head was transfected with a human adenoviral vector expressing VEGF (Ad-hVEGF121). Bone formation in the subchondral necrotic region was analyzed using histology, by measuring the bone mineral density value, and by observing bone trabecular morphology using image analysis.
RESULTS: Revascularization level, bone formation rate, bone quality and quantity, and mineralization level in the subchondral necrotic region of the gene transfection group were significantly higher than the control groups. The control groups had more subchondral bone resorption compared with the gene transfection group.
CONCLUSION: VEGF might promote bone formation and revascularization in the subchondral necrotic region of the femoral head, indirectly protecting the necrotic bone trabecula from absorption and avoiding a reduction in the mechanical function of the subchondral region.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21336201     DOI: 10.1097/TA.0b013e3181f31595

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  3 in total

1.  Osteonecrosis of the femoral head: treatment with ancillary growth factors.

Authors:  Matthew T Houdek; Cody C Wyles; Rafael J Sierra
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

Review 2.  Gene delivery to bone.

Authors:  C H Evans
Journal:  Adv Drug Deliv Rev       Date:  2012-03-26       Impact factor: 15.470

Review 3.  Gene delivery nanoparticles to modulate angiogenesis.

Authors:  Jayoung Kim; Adam C Mirando; Aleksander S Popel; Jordan J Green
Journal:  Adv Drug Deliv Rev       Date:  2016-11-30       Impact factor: 15.470

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.